Daiichi Sankyo, with new data, to seek FDA approval of lung cancer drug BioPharma Dive, 11 Sep 2023 Dive Brief: Daiichi Sankyo will ask the Food and Drug Administration to approve an experimental lung cancer antibody drug after…